|
SNX2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.22124532708767E-14 |
| Normal-vs-Stage2 |
1.17629994633717E-09 |
| Normal-vs-Stage3 |
4.89941420767082E-13 |
| Normal-vs-Stage4 |
1.95832239313631E-12 |
| Stage1-vs-Stage2 |
6.674600E-01 |
| Stage1-vs-Stage3 |
3.908400E-01 |
| Stage1-vs-Stage4 |
5.115700E-02 |
| Stage2-vs-Stage3 |
8.519600E-01 |
| Stage2-vs-Stage4 |
2.319400E-01 |
| Stage3-vs-Stage4 |
2.428800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.55950000000949E-05 |
| Normal-vs-Asian |
1.99109995158153E-09 |
| Caucasian-vs-AfricanAmerican |
2.579800E-01 |
| Caucasian-vs-Asian |
9.586200E-01 |
| AfricanAmerican-vs-Asian |
3.675200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.49480469405717E-14 |
| Normal-vs-Female |
1.62470037423645E-12 |
| Male-vs-Female |
5.628600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.43929354282591E-12 |
| Normal-vs-Age(41-60Yrs) |
1.31006316905768E-14 |
| Normal-vs-Age(61-80Yrs) |
1.63558055987778E-12 |
| Normal-vs-Age(81-100Yrs) |
6.564300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.929000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.536630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.764200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.948800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.613400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.956000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.913820E-01 |
| Classical-VS-Follicular |
5.010000E-02 |
| Classical-VS-Other |
3.183000E-01 |
| Classical-VS-Normal |
1.6743273434372E-12 |
| Tall-VS-Follicular |
9.978200E-01 |
| Tall-VS-Other |
7.148200E-01 |
| Tall-VS-Normal |
1.13200004925318E-09 |
| Follicular-VS-Other |
7.626800E-01 |
| Follicular-VS-Normal |
2.97328828224863E-12 |
| Other-VS-Normal |
2.009700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.4432899320127E-15 |
| Normal-vs-N1 |
2.25264251696444E-12 |
| N0-vs-N1 |
7.312400E-02 |
|
|
